Dose-Finding, Feasibility Study of Optison in Contrast Enhanced U/S for the Detection of Carotid Artery Disease
Status:
Terminated
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find the optimal dose from 3 different dose levels - 0.15 mL,
0.5 mL and 1.5 mL of Optison in assessing the presence of disease of the carotid arteries
when comparing pre-contrast to post-contrast ultrasound (U/S) by dose group.